Da: Majestic Books, Hounslow, Regno Unito
EUR 139,71
Quantità: 3 disponibili
Aggiungi al carrelloCondizione: New.
Da: GreatBookPrices, Columbia, MD, U.S.A.
EUR 156,89
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
Condizione: New.
Da: Biblios, Frankfurt am main, HESSE, Germania
EUR 157,88
Quantità: 3 disponibili
Aggiungi al carrelloCondizione: New.
Da: GreatBookPricesUK, Woodford Green, Regno Unito
EUR 161,80
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
Da: Ria Christie Collections, Uxbridge, Regno Unito
EUR 168,31
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. In.
Da: GreatBookPrices, Columbia, MD, U.S.A.
EUR 186,41
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
Da: GreatBookPricesUK, Woodford Green, Regno Unito
EUR 185,95
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
Lingua: Inglese
Editore: Elsevier Science and Technology, GB, 2023
ISBN 10: 0323991777 ISBN 13: 9780323991773
Da: Rarewaves.com USA, London, LONDO, Regno Unito
EUR 211,31
Quantità: Più di 20 disponibili
Aggiungi al carrelloHardback. Condizione: New. Cancer glycobiology is a blazing hot area of cancer research with aberrant post-translational glycosylations on lipids and proteins considered critical for cancer development and metastasis. The NIH/NCI Alliance of Glycobiologists for Cancer Research is a consortium of (10) tumor glycobiology laboratories funded to investigate how cancer-associated glycans (CAG) impact the development and metastasis of cancer. The hope of this momentous effort is to discover CAGs for use as novel biomarkers to detect early-stage cancer or its aggressive behavior or, alternatively, as novel molecular targets with the promise of a curative approach to cancer therapy. The mission of the 'Alliance' is to study structure and function of CAGs in cancer development and to provide clinically useful biomarkers for detecting cancer early or the potential of metastasis. This charge has stimulated extensive collaborations across US and International institutions to accelerate discovery of glycan-based biomarkers to the forefront of NCI's efforts to diagnose early-stage cancer and provide curative anti-cancer therapies. The main goals of these research efforts are: 1. To identify and study how cancer-associated glycans functionally impact cancer growth and metastasis2. To identify cancer-associated glycans that can serve as biomarkers for the detection or progression of cancer3. To develop cancer-associated glycans as novel therapeutic targets for the treatment and cure of cancer This volume consists of (9) chapters, one from each funded laboratory, that reviews new methods and mechanisms highlighting glycoconjugates and their roles as cancer biomarkers and/or anti-cancer therapeutic targets.
EUR 195,30
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. Historical and Novel Glycobiological Biomarkers of Cancer and Disease Progression Novel Glycobiological Mechanisms Driving Cancer Progression Novel Methods for Discovering Glycobiological Biomarkers of Cancer.
Lingua: Inglese
Editore: Elsevier Science and Technology, GB, 2023
ISBN 10: 0323991777 ISBN 13: 9780323991773
Da: Rarewaves.com UK, London, Regno Unito
EUR 198,91
Quantità: Più di 20 disponibili
Aggiungi al carrelloHardback. Condizione: New. Cancer glycobiology is a blazing hot area of cancer research with aberrant post-translational glycosylations on lipids and proteins considered critical for cancer development and metastasis. The NIH/NCI Alliance of Glycobiologists for Cancer Research is a consortium of (10) tumor glycobiology laboratories funded to investigate how cancer-associated glycans (CAG) impact the development and metastasis of cancer. The hope of this momentous effort is to discover CAGs for use as novel biomarkers to detect early-stage cancer or its aggressive behavior or, alternatively, as novel molecular targets with the promise of a curative approach to cancer therapy. The mission of the 'Alliance' is to study structure and function of CAGs in cancer development and to provide clinically useful biomarkers for detecting cancer early or the potential of metastasis. This charge has stimulated extensive collaborations across US and International institutions to accelerate discovery of glycan-based biomarkers to the forefront of NCI's efforts to diagnose early-stage cancer and provide curative anti-cancer therapies. The main goals of these research efforts are: 1. To identify and study how cancer-associated glycans functionally impact cancer growth and metastasis2. To identify cancer-associated glycans that can serve as biomarkers for the detection or progression of cancer3. To develop cancer-associated glycans as novel therapeutic targets for the treatment and cure of cancer This volume consists of (9) chapters, one from each funded laboratory, that reviews new methods and mechanisms highlighting glycoconjugates and their roles as cancer biomarkers and/or anti-cancer therapeutic targets.
Lingua: Inglese
Editore: Elsevier Science & Technology Feb 2023, 2023
ISBN 10: 0323991777 ISBN 13: 9780323991773
Da: AHA-BUCH GmbH, Einbeck, Germania
EUR 273,24
Quantità: 2 disponibili
Aggiungi al carrelloBuch. Condizione: Neu. Neuware.
Da: Brook Bookstore On Demand, Napoli, NA, Italia
EUR 120,14
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: new. Questo è un articolo print on demand.
Da: Revaluation Books, Exeter, Regno Unito
EUR 155,89
Quantità: 2 disponibili
Aggiungi al carrelloHardcover. Condizione: Brand New. 312 pages. 9.00x6.00x0.94 inches. In Stock. This item is printed on demand.